— Know what they know.
Not Investment Advice

ARDS OTC

Aridis Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -50.0% 1Y: -92.3% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $4457 mcap · 40M float · 0.036% daily turnover · Short 78% of daily vol

Balance Sheet Trends

Total Assets
$15M -45.2% ▼
5Y CAGR: -11.1%
Total Liabilities
$39M -4.8% ▼
5Y CAGR: +20.9%
Shareholders Equity
-$24M -84.8% ▼
Cash & Investments
$5M -75.6% ▼
5Y CAGR: -27.9%
Total Debt
$6M +2.5% ▲
Net Debt
$1M +109.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$24M$21M$8M$20M$5M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$24M$21M$8M$20M$5M
Net Receivables$2M$413K$368K$237K$1M
Inventory-$4M-$413K$0-$237K$0
Other Current Assets$0$4M$4M$4M$2M
Total Current Assets$24M$28M$15M$27M$12M
Property, Plant & Equip.$1M$1M$1M$1M$2M
Goodwill & Intangibles$38K$32K$27K$22K$17K
Long-Term Investments$960K$9K$0$0$0
Other Non-Current Assets$7M$557K$0$1M$905K
Total Non-Current Assets$7M$2M$1M$2M$3M
Total Assets$32M$28M$15M$27M$15M
— Liabilities —
Accounts Payable$2M$2M$2M$5M$2M
Short-Term Debt$0$0$439K$696K$4M
Deferred Revenue$22K$15M$19M$21M$20M
Other Current Liabilities$455K$0$37K$110K$15K
Total Current Liabilities$5M$19M$22M$33M$37M
Long-Term Debt$0$0$276K$5M$0
Other Non-Current Liab.$0$0$228K$363K$0
Total Non-Current Liabilities$0$5M$1M$7M$2M
Total Liabilities$5M$24M$24M$41M$39M
— Equity —
Common Stock$1K$1K$1K$2K$3K
Retained Earnings-$71M-$101M-$123M-$165M-$196M
Accumulated OCI-$491K$0$0$0$5M
Total Stockholders Equity$26M$4M-$9M-$13M-$24M
Total Liabilities & Equity$32M$28M$15M$27M$15M
— Key Metrics —
Total Debt$0$0$715K$6M$6M
Net Debt-$24M-$21M-$8M-$14M$1M
Total Investments$960K$9K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms